|Legal Status||To be confirmed|
Quetiapine is a medicine which is used in depression, schizophrenia, treating mania in people with bipolar disorder, treating depression in people with bipolar disorder and preventing relapses in bipolar disorder. Quetiapine belongs to a class of medicines called antipsychotics. Quetiapine was notified by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) as a potential drug of abuse in 2014.
|Short Term Effects||
Drowsiness, dizziness, lethargy, delirium, agitation, dry mouth, urinary retention, slurred speech and confusion.
Identified in Poland: • N-(2-(dimethylamino)cyclohexyl)-N-methylbenzo[d][1,3]dioxole-5-carboxamide (3,4-methylenedioxy-U-47700)a NPS Opioid
There have been recent deaths and hospitalisations relating to substance use at festivals.: Be aware that over the past few years there has been an increase in the dosage and purity of substances available, in particular MDMA ‘Ecstasy’ pills. Increased purity and dosage means an increase in potential for adverse effects. Pills and powders etc.. may not contain what is intended, different substances have different doses,effects, time of onset and duration. Where WEDINOS have tested pressed pills; the result relates only to the samples analysed and cannot be used to indicate the contents, profile or quality of a wider batch of the substance. This is always the case despite pills having the same logo, shape size and colour.